Vivos Therapeutics, Inc. (VVOS) Reports Q4 Loss, Lags Revenue Estimates

Vivos Therapeutics, Inc. (VVOS) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $3.05 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 34.88%. A quarter ago, it was expected that this company would post a loss of $0.70 per share when it actually produced a loss of $0.40, delivering a surprise of 42.86%. Over the last four quarters, the company h ...